Christine Gan

About

Christine Gan is a leading urological surgeon and researcher whose work has fundamentally advanced the surgical management of bladder cancer. Her primary research focus is on optimizing surgical techniques for radical cystectomy, particularly through rigorous comparative effectiveness trials. Gan is best known as the principal investigator of the landmark CORAL trial, the first early-phase randomised controlled trial to directly compare open, robotic, and laparoscopic radical cystectomy. The initial results, published in 2015 and cited over 337 times, provided crucial short-term safety and feasibility data, while her 2019 follow-up, with 116 citations, delivered the first long-term oncological outcomes from such a three-arm comparison. This work has been instrumental in guiding surgical decision-making and shaping evidence-based practice for patients with invasive bladder cancer. By systematically evaluating these competing approaches, Gan has helped define the role of minimally invasive surgery in urologic oncology. Her contributions have not only influenced clinical protocols but also set a new standard for prospective surgical trials in the field, making her a pivotal figure in the evolution of radical cystectomy.

Research Focus

Key Achievements

Top Papers

1. 1
   A Single-centre Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)

   337 citations · 2015
2. 2
   Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)

   116 citations · 2019
3. 3
   1624 A PILOT PROSPECTIVE SINGLE-CENTRE 3-ARM RANDOMISED CONTROLLED TRIAL OF OPEN, ROBOTIC AND LAPAROSCOPIC (CORAL) RADICAL CYSTECTOMY FOR BLADDER CANCER

   7 citations · 2013

Key Collaborators

Contact & Links